AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Olympmexico.com publica guía 2026 sobre Olymp Trade para México
AGP
Brújula de Brókers lanzó una guía de consumidor actualizada sobre Olymp Trade enfocada en lectores en México, con énfasis en regulación, uso de la plataforma y riesgos.
Ajovy market forecast points to faster growth in migraine prevention
AGP
The Business Research Company says the Ajovy market is set to expand through 2035 as migraine diagnoses rise, preventive treatment gains ground and biologic therapies become more accepted.
Aimovig market seen growing on migraine prevention demand
AGP
The Business Research Company says Aimovig’s global market is set to expand through 2035, driven by rising migraine diagnoses, broader insurance coverage, and growing use of preventive biologics.
Albuked market seen growing as liver disease demand rises
AGP
The Business Research Company says the global Albuked market has long-term growth potential through 2035, driven by rising liver disease cases, ICU demand and interest in safer non-plasma alternatives.
Panama Canal Cuts Neopanamax Draft Limits in Two Stages
AGP
The Panama Canal Authority will trim the maximum draft for Neopanamax vessels on Aug. 26 and again on Sept. 3 as Gatun Lake levels guide water-management decisions.
Panama tops Latin America investment migration ranking
AGP
Global Citizen Solutions ranked 11 active residency programs across Latin America and put Panama first, citing its breadth of qualifying assets, no minimum stay and strong investor demand.
Mexico Cosmetic Center launches stem cell pre-op therapy for surgery recovery
AGP
Mexico Cosmetic Center has launched Stellar Stem Cell Pre-Op Therapy in Tijuana, aiming to reduce inflammation, speed healing and improve cosmetic results for plastic surgery and bariatric patients.
Afstyla market forecast points to growth through 2035
AGP
The Business Research Company says the Afstyla market is gaining traction as hemophilia A diagnoses rise and more patients move toward recombinant factor VIII therapies.
Adstiladrin market report sees growth tied to bladder cancer demand and gene therapy adoption
AGP
The Business Research Company says the global market for Adstiladrin, a gene therapy for high-risk non-muscle-invasive bladder cancer, is being shaped by rising bladder cancer cases, higher healthcare spending, and broader adoption of precision…
HPSI showcases Cummins diesel generator systems at Middle East Energy
AGP
Huaxin Power Systems International Co., Ltd. is presenting its Cummins-powered generator lineup at Middle East Energy in Dubai, targeting demand from contractors, data centers, developers and industrial buyers across the Middle East and beyond….
Afrezza market outlook brightens as diabetes demand rises
AGP
The Business Research Company says the Afrezza market is set for stronger growth through 2035, driven by rising diabetes cases, higher healthcare spending and broader acceptance of inhaled insulin.
Worldreader says nearly 2,000 families joined first All Families Reading Challenge
AGP
Worldreader says nearly 2,000 families in more than 40 countries read together during its first All Families Reading Challenge in September, topping the 10-book goal by a wide margin.
Afrezza market outlook brightens on rising diabetes demand
AGP
The Business Research Company says the global Afrezza market is set for stronger growth through 2035 as diabetes cases rise, healthcare spending increases and inhaled insulin gains wider acceptance.
AAV market to reach $6.65B by 2030 on gene therapy demand
AGP
The adeno-associated viral vectors market is projected to climb from $3.17 billion in 2025 to $6.65 billion by 2030 as gene therapy activity expands worldwide.
Afluria quadrivalent vaccine market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the global Afluria Quadrivalent vaccine market is being shaped by rising flu incidence, broader pediatric immunization and higher healthcare spending.
ARDS market seen reaching $2.42 billion by 2030
AGP
The acute respiratory distress syndrome market is forecast to grow from $1.41 billion in 2025 to $2.42 billion by 2030, driven by rising respiratory illness, ICU expansion and advances in ventilation and ECMO. North America held the largest market…
Adipose tissue stem cell market seen reaching $2.14 billion by 2030
AGP
The global adipose tissue derived stem cell market is forecast to grow from $1.35 billion in 2026 to $2.14 billion by 2030, driven by regenerative medicine, cell-therapy commercialization and broader clinical use. North America led the market in…
Adcetris market seen growing to $2.12 million by 2030
AGP
The Business Research Company says the global Adcetris market is expanding on rising cancer cases, demand for targeted therapies and broader use in oncology.
Afluria vaccine market seen growing on flu demand and aging population
AGP
The Business Research Company says the Afluria vaccine market is set to expand through 2035, driven by seasonal flu outbreaks, broader vaccination coverage and a growing older population.
Admelog market seen growing on diabetes demand and biosimilar adoption
AGP
The Business Research Company says the global Admelog market is set for long-term growth through 2035, driven by rising diabetes cases, expanding biosimilar use and government efforts to contain insulin costs.
Sign up for:
Latin America News Hub
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.